BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+11.69%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.02B
AUM Growth
+$1.02B
Cap. Flow
-$13M
Cap. Flow %
-1.27%
Top 10 Hldgs %
51.66%
Holding
52
New
9
Increased
8
Reduced
25
Closed
1

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$36.7M
2
MRUS icon
Merus
MRUS
$34M
3
IONS icon
Ionis Pharmaceuticals
IONS
$23.8M
4
GLMD icon
Galmed Pharmaceuticals
GLMD
$21M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
$17.9M

Top Sells

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
$94.4M
2
ARQL
Arqule Inc
ARQL
$49.7M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
$14M
4
ARRY
Array Biopharma Inc
ARRY
$6.55M
5
RCUS icon
Arcus Biosciences
RCUS
$3.79M

Sector Composition

1 Healthcare 83.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RCUS icon
26
Arcus Biosciences
RCUS
$1.24B
$11.7M 1.15%
959,840
-309,948
-24% -$3.79M
IRWD icon
27
Ironwood Pharmaceuticals
IRWD
$201M
$11.6M 1.13%
606,715
-4,935,685
-89% -$94.4M
CDTX icon
28
Cidara Therapeutics
CDTX
$1.61B
$10M 0.98%
+1,930,670
New +$10M
PTGX icon
29
Protagonist Therapeutics
PTGX
$3.62B
$9.53M 0.93%
1,417,967
+1,012,367
+250% +$6.8M
OMED
30
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$9.47M 0.92%
4,099,589
-153,600
-4% -$355K
FSTX
31
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$9.31M 0.91%
785,950
-46,297
-6% -$549K
RGLS
32
DELISTED
Regulus Therapeutics
RGLS
$9.02M 0.88%
13,685,204
-289,045
-2% -$191K
SNDX icon
33
Syndax Pharmaceuticals
SNDX
$1.39B
$8.66M 0.85%
1,233,618
-2,000,000
-62% -$14M
VBIV
34
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8.53M 0.83%
3,100,000
– –
ALBO
35
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$7.81M 0.76%
220,000
-5,000
-2% -$178K
CFRX
36
DELISTED
ContraFect Corporation
CFRX
$7.43M 0.73%
3,361,071
-138,929
-4% -$308K
PHXM
37
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$7.21M 0.7%
625,000
– –
XENE icon
38
Xenon Pharmaceuticals
XENE
$2.99B
$6.63M 0.65%
720,830
– –
ONCT
39
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.91M 0.58%
386,134
-223,614
-37% -$3.42M
MACK
40
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$5.45M 0.53%
+1,110,588
New +$5.45M
SURF
41
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$5.45M 0.53%
+334,333
New +$5.45M
ALPN
42
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.87M 0.48%
643,059
-32,700
-5% -$248K
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.51M 0.44%
5,265,000
+265,000
+5% +$227K
FBRX icon
44
Forte Biosciences
FBRX
$138M
$4.4M 0.43%
471,007
-33,476
-7% -$312K
MTEM
45
DELISTED
Molecular Templates, Inc.
MTEM
$3.6M 0.35%
688,629
– –
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.57M 0.35%
1,684,636
– –
EPIX icon
47
ESSA Pharma
EPIX
$11.2M
$2.09M 0.2%
552,791
-9,630,855
-95% +$165K
KDNY
48
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.07M 0.2%
295,965
-510,569
-63% -$3.57M
FRTX
49
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.53M 0.15%
1,332,605
-76,839
-5% -$88.4K
LOXO
50
DELISTED
Loxo Oncology, Inc
LOXO
$709K 0.07%
4,089
-297
-7% -$51.5K
1
2
3